6-hydroxy-5-methoxy-2-indolylcarboxylic acid has been researched along with Disease Exacerbation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arstrand, K; Kågedal, B; Kärnell, R; Lindholm, C; Nilsson, B; Ringborg, U | 1 |
1 other study(ies) available for 6-hydroxy-5-methoxy-2-indolylcarboxylic acid and Disease Exacerbation
| Article | Year |
|---|---|
The value of cysteinyldopa in the follow-up of disseminated malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cysteinyldopa; Disease Progression; Female; Follow-Up Studies; Humans; Indoles; Male; Melanoma; Middle Aged; Skin Neoplasms | 2000 |